Leschnik B - Search Results

1

Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.

Novak M, Schlagenhauf A, Bernhard H, Schweintzger S, Leschnik B, Muntean W. Novak M, et al. Among authors: leschnik b. Blood Coagul Fibrinolysis. 2011 Oct;22(7):588-92. doi: 10.1097/MBC.0b013e328349f190. Blood Coagul Fibrinolysis. 2011. PMID: 21799400

2

Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibition.

Koestenberger M, Gallistl S, Cvirn G, Roschitz B, Petritsch M, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: leschnik b. Thromb Haemost. 2002 Dec;88(6):1012-9. Thromb Haemost. 2002. PMID: 12529753

3

Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition.

Koestenberger M, Gallistl S, Cvirn G, Roschitz B, Rehak T, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: leschnik b. Blood Coagul Fibrinolysis. 2004 Mar;15(2):131-7. doi: 10.1097/00001721-200403000-00004. Blood Coagul Fibrinolysis. 2004. PMID: 15091000

4

Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.

Koestenberger M, Gallistl S, Cvirn G, Baier K, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: leschnik b. Thromb Res. 2005;115(1-2):135-42. doi: 10.1016/j.thromres.2004.07.003. Thromb Res. 2005. PMID: 15567465

5

Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.

Koestenberger M, Gallistl S, Muntean W, Leschnik B, Fritsch P, Cvirn G. Koestenberger M, et al. Among authors: leschnik b. Thromb Haemost. 2005 Jul;94(1):69-74. doi: 10.1160/TH05-01-0041. Thromb Haemost. 2005. PMID: 16113786

6

Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography.

Rosenkranz A, Koestenberger M, Novak M, Cvirn G, Leschnik B, Gamillscheg A, Beitzke A, Muntean W. Rosenkranz A, et al. Among authors: leschnik b. Blood Coagul Fibrinolysis. 2008 Jul;19(5):389-93. doi: 10.1097/MBC.0b013e3282fe7224. Blood Coagul Fibrinolysis. 2008. PMID: 18600087 Clinical Trial.

7

Microparticles in newborn cord blood: slight elevation after normal delivery.

Schweintzger S, Schlagenhauf A, Leschnik B, Rinner B, Bernhard H, Novak M, Muntean W. Schweintzger S, et al. Among authors: leschnik b. Thromb Res. 2011 Jul;128(1):62-7. doi: 10.1016/j.thromres.2011.01.013. Epub 2011 Mar 4. Thromb Res. 2011. PMID: 21376371

8

Prostaglandin E2 levels and platelet function are different in cord blood compared to adults.

Schlagenhauf A, Haidl H, Leschnik B, Leis HJ, Heinemann A, Muntean W. Schlagenhauf A, et al. Among authors: leschnik b. Thromb Haemost. 2015 Jan;113(1):97-106. doi: 10.1160/TH14-03-0218. Epub 2014 Aug 14. Thromb Haemost. 2015. PMID: 25118631

9

New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels.

Haidl H, Zöhrer E, Pohl S, Leschnik B, Weiss EC, Gallistl S, Muntean W, Schlagenhauf A. Haidl H, et al. Among authors: leschnik b. Pediatr Res. 2019 Dec;86(6):719-724. doi: 10.1038/s41390-019-0531-4. Epub 2019 Aug 12. Pediatr Res. 2019. PMID: 31404918

10

Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.

Gallistl S, Cvirn G, Leschnik B, Muntean W. Gallistl S, et al. Among authors: leschnik b. Blood Coagul Fibrinolysis. 2002 Oct;13(7):653-5. doi: 10.1097/00001721-200210000-00012. Blood Coagul Fibrinolysis. 2002. PMID: 12439153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters